Related Experiment Video
Updated: Jun 13, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Migrasomes program tissue microenvironment: from physiology to oncology, future perspectives in clinical advances
Shaosen Zhang1,2, Jiaoting Chen1,2, Yancheng Lai1,2
1Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
None:
Cancer remains a critical global health challenge, necessitating an in-depth investigation into spatiotemporal dimensions. Migrasomes, a class of migration-dependent organelles that sequester spatiotemporal and biochemical cues, offer a previously overlooked pathway for microenvironmental programming during tumor evolution. At the cellular level, migrasomes mediate extensive intercellular communication and material transfer, while facilitating cellular quality control via the extrusion of damaged organelles. Within tissue microenvironments, these organelles exert context-dependent, bidirectional effects, modulating homeostasis in processes such as wound healing, senescence, inflammation, and microbial infection, while being exploited in cancer to drive proliferation, angiogenesis, immunomodulation, and metastasis. This review elucidates the intricate role of migrasomes within tumor microenvironments and other tissue settings, discusses their potential involvement in the transition from tissue homeostasis to malignancy, and evaluates their potential implications for clinical therapeutic strategies, as well as diagnostic and prognostic biomarkers.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

